Literature DB >> 1882844

Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene.

K Kainulainen1, B Steinmann, F Collins, H C Dietz, C A Francomano, A Child, M W Kilpatrick, D J Brock, M Keston, R E Pyeritz.   

Abstract

Marfan syndrome is a dominantly inherited connective tissue disorder with manifestations in the cardiovascular, ocular, and skeletal systems. The diagnosis is hampered by both high variability in the phenotypic expression and late manifestation of symptoms. The cause of Marfan syndrome remains unknown, but our group has recently reported the genetic linkage of Marfan syndrome to a polymorphic marker on chromosome 15. To analyze the possible heterogeneity behind Marfan syndrome, we have performed linkage analyses for four chromosome 15 markers in 17 families from five different populations: Scottish, English, Swiss, American, and Finnish. By combining the linkage data of all the studied families into a LINKMAP analysis we obtained a maximal LOD score of 11.2, which maps the Marfan syndrome locus between D15S25 and D15S45 on the long arm of chromosome 15. The data reveal no evidence for genetic heterogeneity behind Marfan syndrome and provide us with a more precise location of both the Marfan syndrome locus and flanking markers. This information will provide the basis for the DNA diagnostics of Marfan syndrome in the future.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882844      PMCID: PMC1683142     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 3.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

4.  Marfan syndrome: exclusion of genetic linkage to the COL1A2 gene.

Authors:  P Tsipouras; A L Børresen; S Bamforth; P S Harper; K Berg
Journal:  Clin Genet       Date:  1986-11       Impact factor: 4.438

5.  The Marfan syndrome: a deficiency in chemically stable collagen cross-links.

Authors:  R J Boucek; N L Noble; Z Gunja-Smith; W T Butler
Journal:  N Engl J Med       Date:  1981-10-22       Impact factor: 91.245

6.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome.

Authors:  L Pulkkinen; K Kainulainen; T Krusius; P Mäkinen; J Schollin; K H Gustavsson; L Peltonen
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3.

Authors:  H C Dietz; R E Pyeritz; B D Hall; R G Cadle; A Hamosh; J Schwartz; D A Meyers; C A Francomano
Journal:  Genomics       Date:  1991-02       Impact factor: 5.736

8.  Regional assignments of three polymorphic DNA segments on human chromosome 15.

Authors:  J E Brissenden; D C Page; B de Martinville; J Trowsdale; D Botstein; U Francke
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

9.  Exclusion of the alpha 2(I) and alpha 1(III) collagen genes as the mutant loci in a Marfan syndrome family.

Authors:  R Dalgleish; J R Hawkins; M Keston
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

10.  Cell-free synthesis of hyaluronic acid in Marfan syndrome.

Authors:  A Appel; A L Horwitz; A Dorfman
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

View more
  15 in total

Review 1.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 2.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

3.  Understanding Marfan's syndrome.

Authors:  I Young
Journal:  BMJ       Date:  1991-12-07

4.  Molecular heterogeneity: a clinical dilemma. Clinical heterogeneity: a molecular dilemma.

Authors:  M Godfrey
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides.

Authors:  K Kainulainen; L Y Sakai; A Child; F M Pope; L Puhakka; L Ryhänen; A Palotie; I Kaitila; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 6.  Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.

Authors:  D M Milewicz
Journal:  Tex Heart Inst J       Date:  1994

7.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression.

Authors:  Bruno L Lima; Enrico J C Santos; Gustavo R Fernandes; Christian Merkel; Marco R B Mello; Juliana P A Gomes; Marina Soukoyan; Alexandre Kerkis; Silvia M G Massironi; José A Visintin; Lygia V Pereira
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Paucity of skeletal manifestations in Hispanic families with FBN1 mutations.

Authors:  Carlos Villamizar; Ellen S Regalado; Van Tran Fadulu; Sumera N Hasham; Prateek Gupta; Marcia C Willing; Shao-Qing Kuang; Dongchuan Guo; Ann Muilenburg; Richard W Yee; Yuxin Fan; Jeffrey Towbin; Joseph S Coselli; Scott A LeMaire; Dianna M Milewicz
Journal:  Eur J Med Genet       Date:  2009-11-23       Impact factor: 2.708

10.  Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons.

Authors:  G Nijbroek; S Sood; I McIntosh; C A Francomano; E Bull; L Pereira; F Ramirez; R E Pyeritz; H C Dietz
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.